Acta Psychiatr Scand

1. DAMIANI S, Orlandi M, Provenzani U, Bortolin E, et al
   Unraveling Suicidal Ideation and Behaviors in a Global Cohort of Individuals at Clinical High-Risk for Psychosis: Multivariable Correlates and Subthreshold Psychotic Symptoms.
   Acta Psychiatr Scand. 2026 Sep 11. doi: 10.1111/acps.70138.
   

   >> Share

   
   

   
   Br J Psychiatry

2. FERNANDEZ-EGEA E, Krishnadas R
   The clozapine gap in early psychosis: a system problem, not a monitoring one: Commentary on Williams et al, from early intervention in psychosis to intensive care.
   Br J Psychiatry. 2026 Sep 10:1-2. doi: 10.1192/bjp.2026.10782.
   

   >> Share

   
   
3. FORMANEK T, Lynall ME, Osimo EF
   Immune dysregulation in depression and psychosis: summary of current evidence and future perspectives.
   Br J Psychiatry. 2026 Sep 8:1-3. doi: 10.1192/bjp.2026.10761.
   

   >> Share

   
   

   
   Can J Psychiatry

4. YANG L, Ross K, Palmer M, Ye Q, et al
   Adherence and Acceptability of Smartphone- and Wearable-Based Digital Phenotyping in Patients With First-Episode Psychosis: Observance et acceptabilite du phenotypage numerique fonde sur les telephones intelligents et les objets personnels connectes c
   Can J Psychiatry. 2026 Sep 11:7067437261486958. doi: 10.1177/07067437261486958.
   

   >> Share

   
   
5. MIRABELLI J, MacKillop J, Streiner D, Korostil M, et al
   Cannabis Use Interacts With Psychosis Vulnerability in Borderline Personality Disorder: La consommation de cannabis interagit avec la vulnerabilite a la psychose dans le trouble de la personnalite limite.
   Can J Psychiatry. 2026 Sep 11:7067437261486962. doi: 10.1177/07067437261486962.
   

   >> Share

   
   
6. SKIBA RM, Woodward TS, Caramanna I, Honer WG, et al
   A Multivariate Approach to Communication Impoverishment and Cognitive Performance in Treatment-Resistant Schizophrenia: Analyse a plusieurs variables portant sur l'appauvrissement de la communication et la performance cognitive dans les cas de schizop
   Can J Psychiatry. 2026 Sep 7:7067437261484787. doi: 10.1177/07067437261484787.
   

   >> Share

   
   

   
   Clin Neuropharmacol

7. DEUTSCH SI, Elikan J, Spiegel DR, Cockerham MC, et al
   Last of the Just: A Novel Highlighting Descriptive Relations Between Trauma-induced Episodes of Dissociation and Psychosis. Does Pathologic Disruption of NMDA Receptor-mediated Neurotransmission Underlie These Relations and Serve as a Promising Therap
   Clin Neuropharmacol. 2026 Jul 31. doi: 10.1097/WNF.0000000000000700.
   

   >> Share

   
   

   
   J Clin Psychopharmacol

8. OZBAYIR CI, Gonul AS
   Management of Schizophrenia With Clozapine in the Context of Comorbid Waldenstrom's Macroglobulinemia.
   J Clin Psychopharmacol. 2026 Sep 9. doi: 10.1097/JCP.0000000000002256.
   

   >> Share

   
   

   
   Med J Aust

9. SUETANI S, Dark F, Every-Palmer S, Galletly C, et al
   A Summary for Non-Psychiatrists of the Australian and New Zealand Journal of Psychiatry Grading of Recommendations, Assessment, Development and Evaluations (GRADE) Guidelines for the Management of Schizophrenia.
   Med J Aust. 2026;224:e70287.
   

   >> Share

   
   

   
   Mol Psychiatry

10. XIONG Y, Wu G, Tang X, Yang Y, et al
    Dynamic, differentiated clinical trajectories and prediction in clinical high risk for psychosis.
    Mol Psychiatry. 2026 Sep 8. doi: 10.1038/s41380-026-03870.
    

    >> Share

    
    
11. BACH SV, Punzi G, Smith NE, Mukherjee S, et al
    BDNF-DT and BDNF-AS-DT: novel genes in the BDNF locus.
    Mol Psychiatry. 2026;31:6069-6081.
    

    >> Share

    
    

    
    Nat Genet

12. PEYROT WJ, Panagiotaropoulou G, Olde Loohuis LM, Adams MJ, et al
    Distinguishing different psychiatric disorders using DDx-PRS.
    Nat Genet. 2026;58:2371-2380.
    

    >> Share

    
    
13. CHEN Y, Feng Q, Lam M, Yu M, et al
    Contribution of copy number variants to schizophrenia in East Asian populations.
    Nat Genet. 2026 Sep 11. doi: 10.1038/s41588-026-02732.
    

    >> Share

    
    

    
    Psychiatry Res

14. SILVERMAN IH, Kaur D, Campbell LM, Mahmood Z, et al
    Demographic moderators of the relationship between psychiatric diagnosis and functional capacity in people with serious mental illness.
    Psychiatry Res. 2026;365:117386.
    

    >> Share

    
    
15. BURKHARDT E, Lerch S, Fluckiger R, Cavelti M, et al
    Clinical and psychosocial factors related to change and therapy attendance during cognitive-behavioral therapy for young people at ultra high-risk of psychosis.
    Psychiatry Res. 2026;366:117423.
    

    >> Share

    
    

    
    Psychol Med

16. GONZALEZ CHONG R, Obiajulu D, Thibeau H, Safa S, et al
    Stakeholder perspectives on artificial intelligence in schizophrenia care.
    Psychol Med. 2026;56:e265.
    

    >> Share

    
    
17. MILLER-SILVA C, Illingworth BJG, Martey K, Mujirishvili T, et al
    No evidence for a generalised predictive processing deficit in psychosis: A meta-analysis.
    Psychol Med. 2026;56:e268.
    

    >> Share

    
    
18. ASHLEY SA, Merritt K, Solmi F, Luque Laguna P, et al
    Course of head growth from birth to adolescence across the psychosis spectrum.
    Psychol Med. 2026;56:e267.
    

    >> Share

    
    

    
    Schizophr Res

19. PERFALK E, Damgaard JG, Danielsen AA, Ostergaard SD, et al
    Predicting clozapine initiation among patients with schizophrenia via machine learning trained on electronic health record data.
    Schizophr Res. 2026;297:461-471.
    

    >> Share

    
    
20. VAN DER VELDE DM, de Haan L, Batalla A, Sommer IE, et al
    Polysubstance use after remission in first-episode psychosis: Associations with positive symptoms and self-care.
    Schizophr Res. 2026;297:454-460.
    

    >> Share

    
    
21. MORITZ S, Flachsenberg ME, Meinhart A, Ishikawa R, et al
    Should schizophrenia be renamed? Patients' preferences and what anti-stigma campaigns may learn from the history of the term "Black" in the United States.
    Schizophr Res. 2026;297:438-444.
    

    >> Share

    
    
22. JIN JW, Winkler CJ, Blunt HB, Riblet NB, et al
    Effect of dopamine partial agonist antipsychotics on suicide risk in persons with schizophrenia and schizoaffective disorders: A systematic review and meta-analysis.
    Schizophr Res. 2026;297:430-437.
    

    >> Share

    
    
23. WANG X, Tang Q, Xu H, Keshavan MS, et al
    Characteristics of treatment-naive individuals with chronic schizophrenia and the reported reasons for non-treatment: A two-year follow-up study in Northwest China.
    Schizophr Res. 2026;297:420-429.
    

    >> Share

    
    
24. CHEN J, Zhang F, Zhang R, Ji M, et al
    Glymphatic system alterations in schizophrenia evaluated by the DTI-ALPS index: A systematic review and meta-analysis.
    Schizophr Res. 2026;297:403-412.
    

    >> Share

    
    
25. KRONENBUERGER M, Yoshida K, Li PY, Tavakoli E, et al
    Pharmacogenomics of antipsychotic-induced weight gain: A systematic review.
    Schizophr Res. 2026;296:175-198.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share